Decision Diagnostics Corp. (DECN)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Jul 24, 2025
Smartsheet Market Cap
Decision Diagnostics has a market cap or net worth of $380.00 as of August 1, 2025. Its market cap has decreased by -99.00% in one year.
Market Cap
380.00
Enterprise Value
n/a
Revenue
2.13M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since February 7, 2002, Decision Diagnostics's market cap has decreased from 1.15M to 380.00, a decrease of -99.97%. That is a compound annual growth rate of -28.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2025 | 380.00 | - |
| Dec 31, 2024 | 380.00 | - |
| Dec 29, 2023 | 380.00 | -99.00% |
| Dec 30, 2022 | 38.05K | -88.21% |
| Dec 31, 2021 | 322.65K | -94.87% |
| Dec 31, 2020 | 6.30M | 174.65% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.81B |
| Veradigm | 789.71M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 584.53M |
| Glass House Brands | 415.24M |
| Nika Pharmaceuticals | 366.89M |
| Northwest Biotherapeutics | 349.54M |
| CytoDyn | 341.59M |